Tower Research Capital LLC (TRC) - IMMUNOME INC ownership

IMMUNOME INC's ticker is IMNM and the CUSIP is 45257U108. A total of 30 filers reported holding IMMUNOME INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNOME INC
ValueSharesWeighting
Q2 2023$24,046
+343414.3%
3,040
+128.9%
0.00%
Q1 2023$7
+40.0%
1,328
-43.7%
0.00%
Q4 2022$5
-99.9%
2,358
-5.3%
0.00%
Q2 2022$8,000
+700.0%
2,489
+1785.6%
0.00%
Q1 2022$1,000
-91.7%
132
-85.7%
0.00%
Q4 2021$12,000
+500.0%
926
+826.0%
0.00%
Q2 2021$2,000
-98.2%
100
-96.9%
0.00%
-100.0%
Q1 2021$110,000
+124.5%
3,229
-36.3%
0.00%
+100.0%
Q4 2020$49,0005,0700.00%
Other shareholders
IMMUNOME INC shareholders Q2 2021
NameSharesValueWeighting ↓
Prentice Capital Management, LP 112,131$936,2942.88%
Alpine Global Management, LLC 365,971$3,055,8580.77%
Baldwin Investment Management, LLC 25,394$212,0400.04%
Magnus Financial Group LLC 25,759$215,0880.03%
Wealth Architects, LLC 11,110$92,7690.02%
Point72 Asset Management, L.P. 545,919$4,558,4240.01%
Dorsey Wright & Associates 3,100$25,8850.01%
ACADIAN ASSET MANAGEMENT LLC 49,712$4140.00%
Newbridge Financial Services Group, Inc. 225$1,8790.00%
TD ASSET MANAGEMENT INC 127,280$1,062,7880.00%
View complete list of IMMUNOME INC shareholders